Conflict of interest disclosure
Claire Hardie: none known.
Ryckie G Wade: none known.
Justin CR Wormald: none known.
Brian Stafford: none known.
Faye Elliott: none known.
Julia Newton-Bishop: my institution has received a grant from Cancer
Research UK to carry out research looking at melanoma survival. Daily
fees were paid to me when I was Clinical Lead at the National Institute
for Health and Care Excellence (NICE) for the Clinical Melanoma
Guideline. I have been reimbursed for travel expenses when asked to give
talks at academic meetings. None of these were paid from identifiable
commercial entities; conference organisers commonly pool funding sources
including commercial companies. I have done legal work for clinical
negligence claims in the past and the last case is now coming to an end.
These fees were primarily used to support the research group but I did
receive one fee from one client personally. My research group is in
receipt of a number of research grants from Cancer Research UK, the
Medical Research Council, Melanoma Focus, Melanoma Research Alliance and
the National Institutes of Health that are for research unrelated to
this Cochrane work. A single honorarium was accepted for a talk in 2019;
paid to my institution. I receive very small royalties for a textbook
published many years ago. I am invited to around three meetings per year
where my travel costs are paid by the conference organisers. I have not
travelled to meetings where the costs are paid directly by a drug
company. I have listed grants and travel expenses paid to enable me to
complete my research but I do not believe that they reflect a conflict
of interest with respect to this Cochrane work.
Donald Dewar: none known.